NO993435D0 - Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon - Google Patents

Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon

Info

Publication number
NO993435D0
NO993435D0 NO993435A NO993435A NO993435D0 NO 993435 D0 NO993435 D0 NO 993435D0 NO 993435 A NO993435 A NO 993435A NO 993435 A NO993435 A NO 993435A NO 993435 D0 NO993435 D0 NO 993435D0
Authority
NO
Norway
Prior art keywords
transdermal
acid containing
acetylsalicylic acid
therapeutic system
containing therapeutic
Prior art date
Application number
NO993435A
Other languages
English (en)
Norwegian (no)
Other versions
NO993435L (no
Inventor
Michael Horstmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO993435L publication Critical patent/NO993435L/no
Publication of NO993435D0 publication Critical patent/NO993435D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO993435A 1997-01-15 1999-07-12 Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon NO993435D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19701059A DE19701059C2 (de) 1997-01-15 1997-01-15 Acetylsalicylsäure enthaltendes transdermales therapeutisches System mit Resorptionsverstärkung
PCT/EP1998/000013 WO1998031348A1 (fr) 1997-01-15 1998-01-03 Systeme therapeutique transdermique contenant de l'acide acetylsalicylique a resorption renforcee

Publications (2)

Publication Number Publication Date
NO993435L NO993435L (no) 1999-07-12
NO993435D0 true NO993435D0 (no) 1999-07-12

Family

ID=7817375

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993435A NO993435D0 (no) 1997-01-15 1999-07-12 Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon

Country Status (8)

Country Link
EP (1) EP1023053A1 (fr)
JP (1) JP2001508069A (fr)
KR (1) KR20000070228A (fr)
AU (1) AU726094B2 (fr)
CA (1) CA2277366A1 (fr)
DE (1) DE19701059C2 (fr)
NO (1) NO993435D0 (fr)
WO (1) WO1998031348A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19949202A1 (de) * 1999-10-13 2001-05-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure
DE19949252B4 (de) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
DE19959913A1 (de) * 1999-12-11 2001-06-28 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne
KR100448469B1 (ko) * 2001-10-26 2004-09-13 신풍제약주식회사 항염증제의 경피 조성물 및 장치
KR100951750B1 (ko) 2001-11-01 2010-04-09 노바르티스 아게 분무 건조 방법 및 그 조성물
DE10338162B3 (de) † 2003-08-20 2005-06-02 Haldex Brake Products Gmbh Verfahren zum Betreiben einer Druckluftbeschaffungsanlage eines Kraftfahrzeuges sowie Druckluftaufbereitungseinrichtung
DE102005033543A1 (de) * 2005-07-14 2007-01-18 Grünenthal GmbH Ein einen Duftstoff aufweisendes transdermales therapeutisches System
DE102005050431A1 (de) * 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
IT202000014578A1 (it) * 2020-06-18 2021-12-18 Poli Md S R L Dispositivo medicale comprendente acido acetil salicilico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
US5164416A (en) * 1989-02-03 1992-11-17 Lintec Corporation Transdermal therapeutic formulation containing a limonene
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
CA2277366A1 (fr) 1998-07-23
JP2001508069A (ja) 2001-06-19
DE19701059C2 (de) 2000-12-21
WO1998031348A1 (fr) 1998-07-23
AU726094B2 (en) 2000-11-02
NO993435L (no) 1999-07-12
DE19701059A1 (de) 1998-07-16
EP1023053A1 (fr) 2000-08-02
KR20000070228A (ko) 2000-11-25
AU5986298A (en) 1998-08-07

Similar Documents

Publication Publication Date Title
FI973002A7 (fi) Terapeuttinen yhdiste - rasvahappokonjugaatit
FI955259L (fi) Estradiolia sisältävä transdermaalinen terapeuttinen systeemi
EP1015578A4 (fr) Molecules therapeutiques
ID24118A (id) Terapi gabungan
DE69833854D1 (de) Therapeutisches ultraschallsystem
FI971991A7 (fi) 2-syaaniakryylihappoesterit
DE69832055D1 (de) Transdermales abgabesystem
DE59813222D1 (de) Kathetersystem
DE69825987D1 (de) Kathetersystem
ID22878A (id) Komposisi aktif secara terapi
DE69841826D1 (de) Immunitätsteigernde milchsäurebakterien
ID24275A (id) Terapi kombinasi
DK0769017T3 (da) Terapeutiske forbindelser
FI961630A7 (fi) Terapeuttisia aineita
ATE253919T1 (de) Analgetika-kombination
DE59500266D1 (de) Transdermales therapeutisches System zur Applikation von Naloxon
FI962220L (fi) Transdermaalinen terapeuttinen järjestelmä
DK1017392T3 (da) Lægemiddel
DE69606053D1 (de) Modifizierte fluorsulfonsäure
DK0623580T3 (da) 2-Keto-3-methyl-4-hydroxy-valerianesyre
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
NO993435D0 (no) Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon
AU7660900A (en) Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid
NO993855D0 (no) Töyelig transdermalt terapeutisk system
ID17052A (id) Turunan-turunan asam asetat terapeutik

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application